Global Tax Dodging Just One Part of Pfizer’s Corrupt Business Model
Pfizer whines about needing higher drug prices, when rather than investing, it has spent over 100% of its profits on stock buybacks and dividends.
Read more...Pfizer whines about needing higher drug prices, when rather than investing, it has spent over 100% of its profits on stock buybacks and dividends.
Read more...On the fallen status of lower-class whites, and the poor prospects for many of their betters.
Read more...Why the CalPERS carry fee disclosure could affect the debate over ending the carried interest loophole.
Read more...Yet another reason to oppose this truly awful, anti-people deal.
Read more...Clinton can’t beat single payer on policy, resorts to demagoguery. Film at 11 (with notes on the rhetoric used).
Read more...The differences between what mission statements say, and what large organizations do.
Read more...An HIV-level silent epidemic has hit less-educated, middle aged whites, with death rates rising, contrary to patterns in the rest of the world and in other US populations.
Read more...ObamaCare’s “new and improved” website, how and why the co-ops are collapsing, and how the filibuster and the reconciliation process were used when ObamaCare was passed.
Read more...A close reading of how the Times covers ObamaCare, and the neo-liberal assumptions that drive that coverage.
Read more...Health care is a huge industry. Where should we focus if we wish delivery at the point of care to be humane?
Read more...Facts and ideas that threaten the managerialist power structure of health care are not considered appropriate for polite conversation, or public discussion.
Read more...Will ObamaCare get enough healthy people in the pool to be sustainable?
Read more...Recent studies of ObamaCare takeup show the dog won’t eat the dogfood. And experience shows that ObamaCare enables insurance company fraud
Read more...Non-terminal patients are being routed to hospices in a form of Medicare fraud, and the results can be deadly to their health.
Read more...Yves here. As Roy Poses stresses, the media has underreported on the conflicts of interest at work in this FDA nomination. Be sure to read the very long list of Big Pharma names that have supported Dr. Richard Cardiff’s research and provided grants and speaking fees.
Read more...